Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Apr-24 4:39 PM View:  | Kinnate Biopharma Inc. (KNTE) | 03-Apr-24 | Disposition Duplicate | 8,009,730 | -- | -- | (100%) 8.01M to 0 | |
| 14-Feb-24 4:01 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) | 17,713,600 | -- | -- | (100%) 17.71M to 0 | |
| 31-Jan-24 4:11 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion | 2,582,880 | -- | -- | 100% 0 to 2.58M | |
| 31-Jan-24 4:11 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase Duplicate | 444,444 | $18.00 | $7,999,990.00 | 17% 2.58M to 3.03M | |
| 26-Jan-24 7:13 PM View: | Adicet Bio, Inc. (ACET) | 25-Jan-24 | Private Purchase | 3,125,000 | $2.40 | $7,500,000.00 | 38% 8.32M to 11.45M | |
| 19-Jul-23 4:17 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 17-Jul-23 | Private Purchase Duplicate | 479,932 | $3.05 | $1,463,790.00 | 3% 17.23M to 17.71M | |
| 29-Jun-23 4:51 PM View: | Adicet Bio, Inc. (ACET) | 27-Jun-23 | Private Purchase Duplicate | 875,000 | $2.09 | $1,828,750.00 | 12% 7.45M to 8.32M | |
| 02-Jun-23 5:47 PM View: | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
| 08-May-23 5:11 PM View: | Kinnate Biopharma Inc. (KNTE) | 05-May-23 | Purchase | 981,023 | $2.82 | $2,766,480.00 | 14% 7.03M to 8.01M | |
| 08-May-23 5:11 PM View: | Kinnate Biopharma Inc. (KNTE) | 04-May-23 | Private Purchase | 479,909 | $2.75 | $1,319,750.00 | 7% 6.55M to 7.03M | |
| 02-May-23 10:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 02-May-23 | Purchase Duplicate | 338,262 | $2.67 | $903,160.00 | 5% 6.21M to 6.55M | |
| 02-May-23 10:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-May-23 | Purchase Duplicate | 716,157 | $2.62 | $1,876,330.00 | 13% 5.49M to 6.21M | |
| 02-May-23 10:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 28-Apr-23 | Private Purchase Duplicate | 350,749 | $2.55 | $894,410.00 | 7% 5.14M to 5.49M | |
| 22-Feb-23 4:30 PM View: | Kinnate Biopharma Inc. (KNTE) | 17-Feb-23 | Grant | 1,100,000 | -- | -- | 27% 4.04M to 5.14M | |
| 28-Dec-22 5:46 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 23-Dec-22 | Purchase | 137,931 | $7.25 | $1,000,000.00 | 2% 7.48M to 7.62M | |
| 10-Nov-22 4:38 PM View: | Compass Therapeutics, Inc. (CMPX) | 08-Nov-22 | Market Purchase | 402,000 | $3.21 | $1,290,420.00 | 2% 18.39M to 18.79M | (1%) |
| 09-Nov-22 4:29 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 07-Nov-22 | Private Purchase Duplicate | 192,000 | $5.21 | $1,000,320.00 | 1% 17.04M to 17.23M | |
| 18-Aug-22 4:50 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 16-Aug-22 | Private Purchase | 3,690,000 | $2.42 | $8,929,800.00 | 97% 3.79M to 7.48M | |
| 13-May-22 5:48 PM View: | Compass Therapeutics, Inc. (CMPX) | 13-May-22 | Purchase Duplicate | 30,722 | $2.49 | $76,497.80 | < 1% 18.36M to 18.39M | |
| 13-May-22 5:48 PM View: | Compass Therapeutics, Inc. (CMPX) | 12-May-22 | Purchase Duplicate | 97,094 | $2.35 | $228,171.00 | < 1% 18.26M to 18.36M | |
| 13-May-22 5:48 PM View: | Compass Therapeutics, Inc. (CMPX) | 11-May-22 | Private Purchase Duplicate | 64,700 | $1.79 | $115,813.00 | < 1% 18.2M to 18.26M | |
| 10-May-22 6:19 PM View: | Compass Therapeutics, Inc. (CMPX) | 10-May-22 | Purchase | 24,447 | $1.60 | $39,115.20 | < 1% 18.17M to 18.2M | |
| 10-May-22 6:19 PM View: | Compass Therapeutics, Inc. (CMPX) | 09-May-22 | Purchase | 90,712 | $1.56 | $141,511.00 | < 1% 18.08M to 18.17M | |
| 10-May-22 6:19 PM View: | Compass Therapeutics, Inc. (CMPX) | 06-May-22 | Private Purchase | 10,200 | $1.63 | $16,626.00 | < 1% 18.07M to 18.08M | |
| 15-Feb-22 9:51 PM View: | Kinnate Biopharma Inc. (KNTE) | 15-Feb-22 | Purchase Duplicate | 9,000 | $9.96 | $89,640.00 | < 1% 4.03M to 4.04M | |
| 15-Feb-22 9:51 PM View: | Kinnate Biopharma Inc. (KNTE) | 14-Feb-22 | Purchase Duplicate | 30,700 | $9.95 | $305,486.00 | < 1% 4.0M to 4.03M | |
| 15-Feb-22 9:51 PM View: | Kinnate Biopharma Inc. (KNTE) | 11-Feb-22 | Private Purchase Duplicate | 156,000 | $10.22 | $1,594,320.00 | 4% 3.85M to 4.0M | |
| 21-Jan-22 7:22 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 21-Jan-22 | Market Purchase Duplicate | 111,896 | $9.97 | $1,115,600.00 | < 1% 16.93M to 17.04M | (1%) |
| 21-Jan-22 7:22 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 20-Jan-22 | Market Purchase Duplicate | 35,000 | $9.95 | $348,250.00 | < 1% 16.89M to 16.93M | (1%) |
| 21-Jan-22 7:22 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 19-Jan-22 | Market Purchase Duplicate | 11,521 | $9.97 | $114,864.00 | < 1% 16.88M to 16.89M | (1%) |
| 13-Jan-22 7:27 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 13-Jan-22 | Market Purchase Duplicate | 17,320 | $9.43 | $163,328.00 | < 1% 16.87M to 16.88M | 4% |
| 13-Jan-22 7:27 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 12-Jan-22 | Market Purchase Duplicate | 18,897 | $10.06 | $190,104.00 | < 1% 16.85M to 16.87M | (2%) |
| 13-Jan-22 7:27 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 11-Jan-22 | Market Purchase Duplicate | 8,500 | $10.51 | $89,319.00 | < 1% 16.84M to 16.85M | (6%) |
| 14-Dec-21 7:06 PM View: | Adicet Bio, Inc. (ACET) | 10-Dec-21 | Grant Duplicate | 214,285 | $14.00 | $2,999,990.00 | 3% 7.26M to 7.48M | 7% |
| 08-Nov-21 9:12 PM View: | Compass Therapeutics, Inc. (CMPX) | 04-Nov-21 | Purchase Duplicate | 5,357,140 | $3.50 | $18,750,000.00 | 42% 12.71M to 18.07M | |
| 14-Oct-21 5:00 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion Duplicate | 16,213,700 | -- | -- | 100% 16.21M to 32.43M | |
| 14-Oct-21 5:00 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase Duplicate | 625,000 | $16.00 | $10,000,000.00 | 2% 32.43M to 33.05M | |
| 31-Mar-21 5:11 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 30-Mar-21 | Market Sale (Planned) Duplicate | 27,869 | $23.93 | $666,905.00 | (1%) 2.24M to 2.21M | (3%) |
| 31-Mar-21 5:11 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 29-Mar-21 | Market Sale (Planned) Duplicate | 75,555 | $23.31 | $1,761,190.00 | (3%) 2.32M to 2.24M | (6%) |
| 26-Mar-21 5:46 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 26-Mar-21 | Market Sale (Planned) | 27,816 | $23.88 | $664,246.00 | (1%) 2.34M to 2.32M | (3%) |
| 26-Mar-21 5:46 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 25-Mar-21 | Market Sale (Planned) | 51,523 | $24.70 | $1,272,620.00 | (2%) 2.4M to 2.34M | < 1% |
| 26-Mar-21 5:46 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 24-Mar-21 | Market Sale (Planned) | 32,959 | $24.80 | $817,383.00 | (1%) 2.43M to 2.4M | < 1% |
| 23-Mar-21 5:26 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 23-Mar-21 | Market Sale (Planned) Duplicate | 3,992 | $24.32 | $97,085.40 | (< 1%) 2.43M to 2.43M | (1%) |
| 23-Mar-21 5:26 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 22-Mar-21 | Market Sale (Planned) Duplicate | 7,673 | $26.47 | $203,104.00 | (< 1%) 2.44M to 2.43M | 7% |
| 23-Mar-21 5:26 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 19-Mar-21 | Market Sale (Planned) Duplicate | 21,275 | $26.47 | $563,149.00 | (< 1%) 2.46M to 2.44M | 7% |
| 18-Mar-21 9:04 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 18-Mar-21 | Market Sale (Planned) | 6,059 | $28.03 | $169,834.00 | (< 1%) 2.47M to 2.46M | 12% |
| 18-Mar-21 9:04 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 17-Mar-21 | Market Sale (Planned) | 18,790 | $28.43 | $534,200.00 | (< 1%) 2.49M to 2.47M | 13% |
| 18-Mar-21 9:04 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 16-Mar-21 | Market Sale (Planned) | 41,353 | $27.72 | $1,146,310.00 | (2%) 2.53M to 2.49M | 11% |
| 15-Mar-21 8:50 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 15-Mar-21 | Market Sale (Planned) | 89,210 | $29.14 | $2,599,580.00 | (3%) 2.62M to 2.53M | 15% |
| 15-Mar-21 8:50 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 12-Mar-21 | Market Sale (Planned) | 90,521 | $30.29 | $2,741,880.00 | (3%) 2.71M to 2.62M | 19% |